MindBio Therapeutics Corp. (CSE:MBIO)
Canada · Delayed Price · Currency is CAD 0.9000
-0.1200 (-11.76%)
At close: Mar 20, 2026
MindBio Therapeutics Market Cap
MindBio Therapeutics has a market cap or net worth of CAD 4.31 million as of March 20, 2026. Its market cap has increased by 27.80% in one year.
Market Cap
4.31M
Enterprise Value
5.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
Market Cap Chart
Since May 5, 2023, MindBio Therapeutics's market cap has decreased from 79.83M to 4.31M, a decrease of -94.59%. That is a compound annual growth rate of -63.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 4.31M | -28.00% |
| Dec 31, 2025 | 5.99M | 109.60% |
| Dec 31, 2024 | 2.86M | -14.04% |
| Dec 27, 2023 | 3.33M | -95.83% |
| May 5, 2023 | 79.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaTher Holdings | 6.37M |
| Restart Life Sciences | 6.22M |
| Aptose Biosciences | 5.67M |
| Kane Biotech | 5.46M |
| MYND Life Sciences | 5.22M |
| Quest PharmaTech | 5.07M |
| COSCIENS Biopharma | 4.78M |
| XORTX Therapeutics | 4.46M |